Clinical trial
The Goal-direct Treatment of Chronic Bowel Dysfunction
NCT04507945 is registered in ClinicalTrials.gov with Nanjing University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Goal-direct Treatment of Chronic Bowel Dysfunction
- Lead sponsor
- Nanjing University School of Medicine
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- October 1, 2020
- Completion date
- September 30, 2023
- Enrollment
- 50 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
bowel dysfunction